Received Aug 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y019930 | — |
Nurse confirmed there are no medical concerns regarding this report; Nurse stated that during a routine vaccination appointment today, 8/12/2025, a patient moved while an attempt to vaccinate with MMR II, resulting in the patient receiving less than the recommended dose; Additionally, the Nurse stated the patient involved received a dose of MMR II prior to their 12 month of age; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-Jun-2025, prior to their 12 month of age due to traveling outside of the country (Product administered to patient of inappropriate age), the patient received the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. On 12-AUG-2025 (now above the 12 months of age parameter), during a routine vaccination appointment, the patient moved while an attempt to vaccinate with the second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5 ml, lot#: Y019930, expiration date: 04-DEC-2026 (strength, route and anatomical location were not provided) for prohylaxis resulting in the patient receiving less than the recommended dose (Underdose). Both vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT). No adverse events reported.
Sterile diluent